Earnings Call · Q4 FY2023·2024-02-15

Q4 23EPS -4.88%·Rev n/aQ3 23EPS 0.00%·Rev n/aQ2 23EPS -0.67%·Rev n/aQ1 23EPS +14.53%·Rev n/a⚠ consensus missing

AGIOS PHARMACEUTICALS, INC. AGIO

Chris Taylor — Vice President

Brian Goff — Chief Executive Officer

Sarah Gheuens — Chief Medical Officer

Tsveta Milanova — Chief Commercial Officer

Cecilia Jones — Chief Financial Officer

+3.5%1d on move date+2.8% vs SPY3d+4.6%5d+15.0%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more AGIO calls or request research access.

More AGIO calls Browse calls Request research access